Forecasting the effectiveness of indoor residual spraying for reducing dengue burden

Background Historically, mosquito control programs successfully helped contain malaria and yellow fever, but recent efforts have been unable to halt the spread of dengue, chikungunya, or Zika, all transmitted by Aedes mosquitoes. Using a dengue transmission model and results from indoor residual spraying (IRS) field experiments, we investigated how IRS-like campaign scenarios could effectively control dengue in an endemic setting. Methods and findings In our model, we found that high levels of household coverage (75% treated once per year), applied proactively before the typical dengue season could reduce symptomatic infections by 89.7% (median of 1000 simulations; interquartile range [IQR]:[83.0%, 94.8%]) in year one and 78.2% (IQR: [71.2%, 88.0%]) cumulatively over the first five years of an annual program. Lower coverage had correspondingly lower effectiveness, as did reactive campaigns. Though less effective than preventative campaigns, reactive and even post-epidemic interventions retain some effectiveness; these campaigns disrupt inter-seasonal transmission, highlighting an off-season control opportunity. Regardless, none of the campaign scenarios maintain their initial effectiveness beyond two seasons, instead stabilizing at much lower levels of benefit: in year 20, median effectiveness was only 27.3% (IQR: [-21.3%, 56.6%]). Furthermore, simply ceasing an initially successful program exposes a population with lowered herd immunity to the same historical threat, and we observed outbreaks more than four-fold larger than pre-intervention outbreaks. These results do not take into account evolving insecticide resistance, thus long-term effectiveness may be lower if new, efficacious insecticides are not developed. Conclusions Using a detailed agent-based dengue transmission model for Yucatán State, Mexico, we predict that high coverage indoor residual spraying (IRS) interventions can largely eliminate transmission for a few years, when applied a few months before the typical seasonal epidemic peak. However, vector control succeeds by preventing infections, which precludes natural immunization. Thus, as a population benefits from mosquito control, it gradually loses naturally acquired herd immunity, and the control effectiveness declines; this occurs across all of our modeled scenarios, and is consistent with other empirical work. Long term control that maintains early effectiveness would require some combination of increasing investment, complementary interventions such as vaccination, and control programs across a broad region to diminish risk of importation.

[1]  A. Rothman Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms , 2011, Nature Reviews Immunology.

[2]  M. Thomson,et al.  A model to simulate the impact of timing, coverage and transmission intensity on the effectiveness of indoor residual spraying (IRS) for malaria control , 2006, Tropical medicine & international health : TM & IH.

[3]  P. Pitisuttithum,et al.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial , 2014, The Lancet.

[4]  Hiroshi Nishiura,et al.  Mathematical and statistical analyses of the spread of dengue , 2006 .

[5]  S. Ritchie,et al.  Deltamethrin resistance in Aedes aegypti results in treatment failure in Merida, Mexico , 2017, PLoS neglected tropical diseases.

[6]  S. Nair,et al.  Molecular Surveillance Identifies Multiple Transmissions of Typhoid in West Africa , 2016, PLoS neglected tropical diseases.

[7]  G. Giglioli An investigation of the house-frequenting habits of mosquitoes of the British Guiana coastland in relation to the use of DDT. , 1948, The American journal of tropical medicine and hygiene.

[8]  Duane J. Gubler,et al.  A Critical Assessment of Vector Control for Dengue Prevention , 2015, PLoS neglected tropical diseases.

[9]  Kai Blin,et al.  Ten Simple Rules for Taking Advantage of Git and GitHub , 2014, bioRxiv.

[10]  Mark Rowland,et al.  A New Long-Lasting Indoor Residual Formulation of the Organophosphate Insecticide Pirimiphos Methyl for Prolonged Control of Pyrethroid-Resistant Mosquitoes: An Experimental Hut Trial in Benin , 2013, PloS one.

[11]  H. Nishiura,et al.  Preliminary estimation of the basic reproduction number of Zika virus infection during Colombia epidemic, 2015-2016. , 2016, Travel medicine and infectious disease.

[12]  G. Carrasquilla,et al.  Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.

[13]  J. Velázquez,et al.  Prevalencia de anticuerpos contra virus Dengue en Yucatán, México, 1985 , 1989 .

[14]  J. Stanaway,et al.  The global economic burden of dengue: a systematic analysis. , 2016, The Lancet. Infectious diseases.

[15]  M. Miranda,et al.  The impact of indoor residual spraying of deltamethrin on dengue vector populations in the Peruvian Amazon. , 2016, Acta tropica.

[16]  Ted M Ross Dengue Virus , 2010, Clinics in Laboratory Medicine.

[17]  A. Lopata,et al.  IgE Reactivity of Blue Swimmer Crab (Portunus pelagicus) Tropomyosin, Por p 1, and Other Allergens; Cross-Reactivity with Black Tiger Prawn and Effects of Heating , 2013, PloS one.

[18]  S. Ghosh,et al.  Village‐scale (Phase III) evaluation of the efficacy and residual activity of SumiShield® 50 WG (Clothianidin 50%, w/w) for indoor spraying for the control of pyrethroid‐resistant Anopheles culicifacies Giles in Karnataka state, India , 2018, Tropical medicine & international health : TM & IH.

[19]  O. Horstick,et al.  Effectiveness of peridomestic space spraying with insecticide on dengue transmission; systematic review , 2010, Tropical medicine & international health : TM & IH.

[20]  A. Wilder-Smith,et al.  Epidemiology of dengue: past, present and future prospects , 2013, Clinical epidemiology.

[21]  F. L. Soper The 1964 status of Aedes aegypti eradication and yellow fever in the Americas. , 1965, The American journal of tropical medicine and hygiene.

[22]  David L. Smith,et al.  The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus , 2015, eLife.

[23]  Laith Yakob,et al.  A Mathematical Model of Chikungunya Dynamics and Control: The Major Epidemic on Réunion Island , 2013, PloS one.

[24]  M. Hashizume,et al.  Optimal Timing of Insecticide Fogging to Minimize Dengue Cases: Modeling Dengue Transmission among Various Seasonalities and Transmission Intensities , 2011, PLoS neglected tropical diseases.

[25]  M. Halloran,et al.  The dengue vaccine pipeline: Implications for the future of dengue control. , 2015, Vaccine.

[26]  T. Scott,et al.  Defining Challenges and Proposing Solutions for Control of the Virus Vector Aedes aegypti , 2008, PLoS medicine.

[27]  M. Nathan,et al.  Eradication of Aedes aegypti on Cayman Brac and Little Cayman, West Indies, with Abate (Temephos) in 1970-1971. , 1982, Bulletin of the Pan American Health Organization.

[28]  E. C. Holmes,et al.  Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok , 2006, Proceedings of the National Academy of Sciences.

[29]  S. Ritchie,et al.  Combining contact tracing with targeted indoor residual spraying significantly reduces dengue transmission , 2017, Science Advances.

[30]  Dengue vaccine: WHO position paper – July 2016. , 2016, Releve epidemiologique hebdomadaire.

[31]  Mario Recker,et al.  The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study , 2016, PLoS medicine.

[32]  Anthony S Fauci,et al.  Zika Virus in the Americas--Yet Another Arbovirus Threat. , 2016, The New England journal of medicine.

[33]  L. Bowman,et al.  Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis , 2016, PLoS neglected tropical diseases.

[34]  David L. Smith,et al.  Quantifying the Epidemiological Impact of Vector Control on Dengue , 2016, PLoS neglected tropical diseases.

[35]  M Elizabeth Halloran,et al.  Projected Impact of Dengue Vaccination in Yucatán, Mexico , 2016, PLoS neglected tropical diseases.

[36]  D. Gubler,et al.  Dengue Prevention and 35 Years of Vector Control in Singapore , 2006, Emerging infectious diseases.

[37]  A. Sabin Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.

[38]  Karthik Gangavarapu,et al.  Genome sequencing reveals Zika virus diversity and spread in the Americas , 2017, bioRxiv.

[39]  Amy C Morrison,et al.  Vector dynamics and transmission of dengue virus: implications for dengue surveillance and prevention strategies: vector dynamics and dengue prevention. , 2010, Current topics in microbiology and immunology.

[40]  Pejman Rohani,et al.  Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity , 2013, Journal of The Royal Society Interface.

[41]  T. Scott,et al.  Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus Transmission , 2010, PLoS neglected tropical diseases.

[42]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[43]  Duane J. Gubler,et al.  Dengue, Urbanization and Globalization: The Unholy Trinity of the 21st Century , 2011, Tropical medicine and health.

[44]  R. Anderson,et al.  Measles in developing countries. Part II. The predicted impact of mass vaccination , 1988, Epidemiology and Infection.

[45]  S. Weaver Arrival of Chikungunya Virus in the New World: Prospects for Spread and Impact on Public Health , 2014, PLoS neglected tropical diseases.

[46]  F. Bassetti,et al.  Polyandry Is a Common Event in Wild Populations of the Tsetse Fly Glossina fuscipes fuscipes and May Impact Population Reduction Measures , 2011, PLoS neglected tropical diseases.

[47]  G. Vazquez-Prokopec,et al.  Indoor Resting Behavior of Aedes aegypti (Diptera: Culicidae) in Acapulco, Mexico , 2016, Journal of Medical Entomology.

[48]  O. Horstick,et al.  Dengue vector-control services: how do they work? A systematic literature review and country case studies. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  Daniel J. Laydon,et al.  Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment , 2016, Science.

[50]  M. Rowland,et al.  Long-lasting control of Anopheles arabiensis by a single spray application of micro-encapsulated pirimiphos-methyl (Actellic® 300 CS) , 2014, Malaria Journal.

[51]  Kenichi W. Okamoto,et al.  Integrating Transgenic Vector Manipulation with Clinical Interventions to Manage Vector-Borne Diseases , 2016, PLoS Comput. Biol..